Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Significance of KDM6A mutation in bladder cancer immune escape.

BMC cancer - 29 May 2021

Chen Xingxing, Lin Xuehua, Pang Guofu, Deng Jian, Xie Qun, Zhang Zhengrong

Abstract excerpt

BACKGROUND: Bladder cancer (BC) is the fourth most prevalent neoplasm in men and is associated with high tumour recurrence rates, leading to major treatment challenges. Lysine-specific demethylase 6A (KDM6A) is frequently mutated in several cancer types; however, its effects on tumour progression and clinical outcome in BC remain unclear. Here, we explored the potential role of KDM6A in regulating the antitumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Datasets as Topic
Share to Follow-Up Studies
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Histone Demethylases

Share to Tumor Escape

Share to Tumor Microenvironment

Share to Urinary Bladder

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 34051747
DOI: 10.1186/s12885-021-08372-9
PMCID: PMC8164329

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Significance of KDM6A mutation in bladder cancer immune escape.PMID 34051747Read ↗

Significance of KDM6A Mutation in Bladder Cancer Immune EscapeSemantic proximity Read ↗

Significance of KDM6A Mutation in Bladder Cancer Immune EscapeSemantic proximity Read ↗

Kdm6a Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with p53 DysfunctionSemantic proximity Read ↗

CDK6 as a Biomarker for Immunotherapy, Drug Sensitivity, and Prognosis in Bladder Cancer: Bioinformatics and Immunohistochemical Analysis.Semantic proximity Read ↗

A Pan-Cancer Analysis Revealing the Dual Roles of Lysine (K)-Specific Demethylase 6B in Tumorigenesis and ImmunitySemantic proximity Read ↗

Loss of KDM6A-mediated genomic instability and metabolic reprogramming differentially regulates responses to immune checkpoint therapy and chemotherapy in bladder cancerSemantic proximity Read ↗

Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer.Semantic proximity Read ↗

Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascadeSemantic proximity Read ↗

EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients.Semantic proximity Read ↗

Loss of KDM6A-mediated genomic instability and metabolic reprogramming regulates response to therapeutic perturbations in bladder cancer.Semantic proximity Read ↗

Multi-omics analysis of tumor mutation burden combined with immune infiltrates in bladder urothelial carcinoma.Semantic proximity Read ↗

Integrative Analysis Reveals the Prognostic Effects of Epigenetic Regulators in Bladder CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.